April 22, 2020

Multicenter initial guidance on use of antivirals for children with COVID-19/SARS-CoV-2

Category: Article Summary

Topic: Clinical Characteristics and Health Care Setting

• This paper presents a guidance based on best available evidence and expert opinion from a panel of pediatric infectious diseases physicians and pharmacists from 18 geographically diverse North American institutions. It discourages the use of antivirals in most COVID-19 pediatric patients. For children who develop severe or critical disease, this guidance offers approaches for decision-making regarding use of antivirals.

Chiotos et al. (Apr 22, 2020). Multicenter initial guidance on use of antivirals for children with COVID-19/SARS-CoV-2. Jour of the Ped Infect Dis. https://doi.org/10.1093/jpids/piaa045